Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Sep 23, 2026, 4:00 PM EDT
1.210
+0.120 (11.01%)
After-hours: Sep 23, 2026, 7:54 PM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $4.03 million as of September 23, 2026. Its market cap has decreased by -54.51% in one year.
Market Cap
4.03M
Enterprise Value
1.90M
1-Year Change
-54.51%
Ranking
Category
Stock Price
$1.09
ChartMarket Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.83M to $4.03M, a decrease of -98.53%. That is a compound annual growth rate of -57.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 4.03M | -52.96% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.45M | -64.38% |
| Dec 30, 2021 | 282.03M | 3.00% |
| Nov 1, 2021 | 273.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 4.70M |
| PharmaCyte Biotech | 4.60M |
| Dermata Therapeutics | 4.50M |
| Lakewood-Amedex Biotherapeutics | 4.22M |
| 60 Degrees Pharmaceuticals | 4.08M |
| Artelo Biosciences | 4.00M |
| Jupiter Neurosciences | 3.92M |
| Mustang Bio | 3.87M |